| UniProt ID | ALS2_HUMAN | |
|---|---|---|
| UniProt AC | Q96Q42 | |
| Protein Name | Alsin | |
| Gene Name | ALS2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1657 | |
| Subcellular Localization | ||
| Protein Description | May act as a GTPase regulator. Controls survival and growth of spinal motoneurons (By similarity).. | |
| Protein Sequence | MDSKKRSSTEAEGSKERGLVHIWQAGSFPITPERLPGWGGKTVLQAALGVKHGVLLTEDGEVYSFGTLPWRSGPVEICPSSPILENALVGQYVITVATGSFHSGAVTDNGVAYMWGENSAGQCAVANQQYVPEPNPVSIADSEASPLLAVRILQLACGEEHTLALSISREIWAWGTGCQLGLITTAFPVTKPQKVEHLAGRVVLQVACGAFHSLALVQCLPSQDLKPVPERCNQCSQLLITMTDKEDHVIISDSHCCPLGVTLTESQAENHASTALSPSTETLDRQEEVFENTLVANDQSVATELNAVSAQITSSDAMSSQQNVMGTTEISSARNIPSYPDTQAVNEYLRKLSDHSVREDSEHGEKPVPSQPLLEEAIPNLHSPPTTSTSALNSLVVSCASAVGVRVAATYEAGALSLKKVMNFYSTTPCETGAQAGSSAIGPEGLKDSREEQVKQESMQGKKSSSLVDIREEETEGGSRRLSLPGLLSQVSPRLLRKAARVKTRTVVLTPTYSGEADALLPSLRTEVWTWGKGKEGQLGHGDVLPRLQPLCVKCLDGKEVIHLEAGGYHSLALTAKSQVYSWGSNTFGQLGHSDFPTTVPRLAKISSENGVWSIAAGRDYSLFLVDTEDFQPGLYYSGRQDPTEGDNLPENHSGSKTPVLLSCSKLGYISRVTAGKDSYLALVDKNIMGYIASLHELATTERRFYSKLSDIKSQILRPLLSLENLGTTTTVQLLQEVASRFSKLCYLIGQHGASLSSFLHGVKEARSLVILKHSSLFLDSYTEYCTSITNFLVMGGFQLLAKPAIDFLNKNQELLQDLSEVNDENTQLMEILNTLFFLPIRRLHNYAKVLLKLATCFEVASPEYQKLQDSSSCYECLALHLGRKRKEAEYTLGFWKTFPGKMTDSLRKPERRLLCESSNRALSLQHAGRFSVNWFILFNDALVHAQFSTHHVFPLATLWAEPLSEEAGGVNGLKITTPEEQFTLISSTPQEKTKWLRAISQAVDQALRGMSDLPPYGSGSSVQRQEPPISRSAKYTFYKDPRLKDATYDGRWLSGKPHGRGVLKWPDGKMYSGMFRNGLEDGYGEYRIPNKAMNKEDHYVGHWKEGKMCGQGVYSYASGEVFEGCFQDNMRHGHGLLRSGKLTSSSPSMFIGQWVMDKKAGYGVFDDITRGEKYMGMWQDDVCQGNGVVVTQFGLYYEGNFHLNKMMGNGVLLSEDDTIYEGEFSDDWTLSGKGTLTMPNGDYIEGYFSGEWGSGIKITGTYFKPSLYESDKDRPKVFRKLGNLAVPADEKWKAVFDECWRQLGCEGPGQGEVWKAWDNIAVALTTSRRQHRDSPEILSRSQTQTLESLEFIPQHVGAFSVEKYDDIRKYLIKACDTPLHPLGRLVETLVAVYRMTYVGVGANRRLLQEAVKEIKSYLKRIFQLVRFLFPELPEEGSTIPLSAPLPTERKSFCTGKSDSRSESPEPGYVVTSSGLLLPVLLPRLYPPLFMLYALDNDREEDIYWECVLRLNKQPDIALLGFLGVQRKFWPATLSILGESKKVLPTTKDACFASAVECLQQISTTFTPSDKLKVIQQTFEEISQSVLASLHEDFLWSMDDLFPVFLYVVLRARIRNLGSEVHLIEDLMDPYLQHGEQGIMFTTLKACYYQIQREKLN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 9 | Phosphorylation | DSKKRSSTEAEGSKE CCCCCCCCCCCCCCC | 40.22 | 28985074 | |
| 31 | Phosphorylation | QAGSFPITPERLPGW ECCCCCCCCCCCCCC | 21.23 | 46162777 | |
| 41 | Ubiquitination | RLPGWGGKTVLQAAL CCCCCCHHHHHHHHH | 31.36 | - | |
| 166 | Phosphorylation | EEHTLALSISREIWA CCCEEHHEEEHHHHH | 16.95 | 24719451 | |
| 353 | Phosphorylation | NEYLRKLSDHSVRED HHHHHHHCCCCCCCC | 35.99 | 26657352 | |
| 356 | Phosphorylation | LRKLSDHSVREDSEH HHHHCCCCCCCCCCC | 28.06 | 29449344 | |
| 361 | Phosphorylation | DHSVREDSEHGEKPV CCCCCCCCCCCCCCC | 27.09 | 69013021 | |
| 417 | Phosphorylation | TYEAGALSLKKVMNF EEECCCCCHHHHHCC | 37.29 | 24719451 | |
| 425 | Phosphorylation | LKKVMNFYSTTPCET HHHHHCCCCCCCCCC | 10.49 | 23879269 | |
| 426 | Phosphorylation | KKVMNFYSTTPCETG HHHHCCCCCCCCCCC | 22.97 | 23879269 | |
| 464 | Phosphorylation | ESMQGKKSSSLVDIR HHHCCCCCCCCEECC | 28.75 | 30266825 | |
| 465 | Phosphorylation | SMQGKKSSSLVDIRE HHCCCCCCCCEECCH | 36.25 | 30266825 | |
| 466 | Phosphorylation | MQGKKSSSLVDIREE HCCCCCCCCEECCHH | 39.23 | 19664994 | |
| 475 | Phosphorylation | VDIREEETEGGSRRL EECCHHHCCCCCCCC | 43.12 | 23403867 | |
| 479 | Phosphorylation | EEETEGGSRRLSLPG HHHCCCCCCCCCHHH | 25.69 | 23403867 | |
| 481 | Methylation | ETEGGSRRLSLPGLL HCCCCCCCCCHHHHH | 30.26 | - | |
| 483 | Phosphorylation | EGGSRRLSLPGLLSQ CCCCCCCCHHHHHHH | 30.61 | 19664994 | |
| 489 | Phosphorylation | LSLPGLLSQVSPRLL CCHHHHHHHCCHHHH | 33.31 | 30266825 | |
| 492 | Phosphorylation | PGLLSQVSPRLLRKA HHHHHHCCHHHHHHH | 9.18 | 19664994 | |
| 506 | Phosphorylation | AARVKTRTVVLTPTY HCCCCCCEEEECCCC | 21.87 | 25850435 | |
| 510 | Phosphorylation | KTRTVVLTPTYSGEA CCCEEEECCCCCCCH | 11.28 | 25850435 | |
| 512 | Phosphorylation | RTVVLTPTYSGEADA CEEEECCCCCCCHHH | 25.69 | 25850435 | |
| 513 | Phosphorylation | TVVLTPTYSGEADAL EEEECCCCCCCHHHH | 18.84 | 25954137 | |
| 514 | Phosphorylation | VVLTPTYSGEADALL EEECCCCCCCHHHHC | 32.41 | 25850435 | |
| 523 | Phosphorylation | EADALLPSLRTEVWT CHHHHCHHHEEEEEE | 30.38 | 24719451 | |
| 526 | Phosphorylation | ALLPSLRTEVWTWGK HHCHHHEEEEEEECC | 39.94 | 46162783 | |
| 530 | Phosphorylation | SLRTEVWTWGKGKEG HHEEEEEEECCCCCC | 29.52 | 46162789 | |
| 533 | Malonylation | TEVWTWGKGKEGQLG EEEEEECCCCCCCCC | 59.37 | 26320211 | |
| 533 | Acetylation | TEVWTWGKGKEGQLG EEEEEECCCCCCCCC | 59.37 | 19608861 | |
| 644 | Phosphorylation | YSGRQDPTEGDNLPE ECCCCCCCCCCCCCC | 61.97 | 22210691 | |
| 656 | Phosphorylation | LPENHSGSKTPVLLS CCCCCCCCCCCEEEE | 36.05 | 22210691 | |
| 658 | Phosphorylation | ENHSGSKTPVLLSCS CCCCCCCCCEEEEEC | 21.96 | 22210691 | |
| 677 | Ubiquitination | ISRVTAGKDSYLALV EEEEECCCCCEEEEE | 40.83 | - | |
| 714 | Phosphorylation | SKLSDIKSQILRPLL HHHHHHHHHHHHHHH | 23.84 | 46162771 | |
| 849 (in isoform 1) | Ubiquitination | - | 24.05 | 21890473 | |
| 849 | Ubiquitination | RRLHNYAKVLLKLAT HHHHHHHHHHHHHHH | 24.05 | 21890473 | |
| 849 | Ubiquitination | RRLHNYAKVLLKLAT HHHHHHHHHHHHHHH | 24.05 | 21890473 | |
| 906 | Phosphorylation | FPGKMTDSLRKPERR CCCCCCCCCCCHHHH | 22.40 | 26091039 | |
| 993 | Ubiquitination | ISSTPQEKTKWLRAI ECCCHHHHHHHHHHH | 50.59 | - | |
| 1036 | Phosphorylation | PISRSAKYTFYKDPR CCCCCCCEEEECCCC | 11.20 | 28152594 | |
| 1037 | Phosphorylation | ISRSAKYTFYKDPRL CCCCCCEEEECCCCC | 21.56 | 28152594 | |
| 1039 | Phosphorylation | RSAKYTFYKDPRLKD CCCCEEEECCCCCCC | 13.49 | 28152594 | |
| 1055 | Phosphorylation | TYDGRWLSGKPHGRG EECCCCCCCCCCCCC | 37.50 | 108417795 | |
| 1057 | Ubiquitination | DGRWLSGKPHGRGVL CCCCCCCCCCCCCCE | 30.39 | - | |
| 1084 | Phosphorylation | RNGLEDGYGEYRIPN CCCCCCCCCCCCCCC | 21.07 | 7067023 | |
| 1144 | Phosphorylation | LLRSGKLTSSSPSMF CCCCCCCCCCCCCCC | 30.01 | 27251275 | |
| 1145 | Phosphorylation | LRSGKLTSSSPSMFI CCCCCCCCCCCCCCC | 38.98 | 28348404 | |
| 1146 | Phosphorylation | RSGKLTSSSPSMFIG CCCCCCCCCCCCCCE | 40.82 | 28348404 | |
| 1147 | Phosphorylation | SGKLTSSSPSMFIGQ CCCCCCCCCCCCCEE | 22.29 | 24719451 | |
| 1149 | Phosphorylation | KLTSSSPSMFIGQWV CCCCCCCCCCCEEEH | 28.42 | 28348404 | |
| 1160 | Ubiquitination | GQWVMDKKAGYGVFD EEEHHCCCCCCCCCC | 42.66 | - | |
| 1281 | Acetylation | DRPKVFRKLGNLAVP CCCHHHHHHCCCCCC | 49.64 | 20167786 | |
| 1292 | Acetylation | LAVPADEKWKAVFDE CCCCCCHHHHHHHHH | 55.32 | 7696719 | |
| 1335 | Phosphorylation | SRRQHRDSPEILSRS CCCCCCCCHHHHCCH | 25.12 | 23401153 | |
| 1340 | Phosphorylation | RDSPEILSRSQTQTL CCCHHHHCCHHCCCH | 35.23 | 23403867 | |
| 1342 | Phosphorylation | SPEILSRSQTQTLES CHHHHCCHHCCCHHH | 33.92 | 28857561 | |
| 1344 | Phosphorylation | EILSRSQTQTLESLE HHHCCHHCCCHHHHC | 25.43 | 17525332 | |
| 1346 | Phosphorylation | LSRSQTQTLESLEFI HCCHHCCCHHHHCCC | 35.56 | 27251275 | |
| 1349 | Phosphorylation | SQTQTLESLEFIPQH HHCCCHHHHCCCHHH | 35.99 | 113332709 | |
| 1394 | Phosphorylation | VETLVAVYRMTYVGV HHHHHHHHHHHHCCC | 5.73 | 22817900 | |
| 1398 | Phosphorylation | VAVYRMTYVGVGANR HHHHHHHHCCCCHHH | 5.95 | 22817900 | |
| 1417 | Phosphorylation | EAVKEIKSYLKRIFQ HHHHHHHHHHHHHHH | 41.16 | 28851738 | |
| 1452 | Phosphorylation | PLPTERKSFCTGKSD CCCCCCCCCCCCCCC | 31.60 | 24719451 | |
| 1458 | Phosphorylation | KSFCTGKSDSRSESP CCCCCCCCCCCCCCC | 42.01 | 22115753 | |
| 1460 | Phosphorylation | FCTGKSDSRSESPEP CCCCCCCCCCCCCCC | 44.81 | 30278072 | |
| 1462 | Phosphorylation | TGKSDSRSESPEPGY CCCCCCCCCCCCCCE | 46.51 | 22167270 | |
| 1464 | Phosphorylation | KSDSRSESPEPGYVV CCCCCCCCCCCCEEE | 35.49 | 22167270 | |
| 1469 | Phosphorylation | SESPEPGYVVTSSGL CCCCCCCEEEECCCC | 11.49 | 22167270 | |
| 1472 | Phosphorylation | PEPGYVVTSSGLLLP CCCCEEEECCCCCHH | 13.71 | 28176443 | |
| 1473 | Phosphorylation | EPGYVVTSSGLLLPV CCCEEEECCCCCHHH | 15.70 | 28176443 | |
| 1474 | Phosphorylation | PGYVVTSSGLLLPVL CCEEEECCCCCHHHH | 24.88 | 28176443 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ALS2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ALS2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ALS2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NEK1_HUMAN | NEK1 | physical | 28514442 | |
| CU002_HUMAN | C21orf2 | physical | 28514442 | |
| RBM6_HUMAN | RBM6 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 205100 | Amyotrophic lateral sclerosis 2 (ALS2) | |||||
| 606353 | Juvenile primary lateral sclerosis (JPLS) | |||||
| 607225 | Infantile-onset ascending spastic paralysis (IAHSP) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-533, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483 AND SER-492, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1464, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483 AND SER-492, ANDMASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-483 AND SER-492, ANDMASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1464, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1344, AND MASSSPECTROMETRY. | |